ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,915, issued on May 20, was assigned to MIRATI THERAPEUTICS INC. (Princeton, N.J.).
"SOS1 inhibitors" was invented by Matthew Arnold Marx (San Diego), John Michael Ketcham (Carlsbad, Calif.), Christopher Ronald Smith (San Diego), John David Lawson (San Diego), Aaron Craig Burns (San Diego), Xiaolun Wang (San Diego), Svitlana Kulyk (Redwood City, Calif.) and Anthony Ivetac (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating cancer using compounds that inhibit Son of sevenless homolog 1 (SOS1) activity and pharmaceutical compositions containing such compounds."
The patent was filed on Nov. 29,...